Came across this recent article discussing the progress of MSB, and two other ASX listed companies, NOX and DXB, all targeting treatments for covid-19 related ARDS.
https://kalkinemedia.com/au/noxopha...ace-to-develop-covid-19-treatment-nox-msb-dxb
The conclusion of the article mirrors my view of the current worldwide potential of an effective ARDS treatment:
"The rising number of coronavirus cases and non-availability of any specific treatment or vaccine to prevent or treat COVID-19 so far, offer an enormous commercial opportunity for all these healthcare players to discover a successful treatment for the lethal disease. As death rate associated with ARDS caused by any factor (including coronavirus) is considerably high, benefits of a fast-tracked treatment are likely to extend beyond the impact of COVID-19."
Apologies if this has already been posted. Herro
Came across this recent article discussing the progress of MSB,...
-
- There are more pages in this discussion • 14,209 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
-0.050(4.69%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.04 | $1.00 | $1.588M | 1.555M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 26831 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 74249 | 18 |
View Market Depth
| Last trade - 11.37am 04/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |